Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies.
Phase of Trial: Phase III
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Fludarabine (Primary) ; Busulfan; Melphalan
- Indications Acute myeloid leukaemia; Aplastic anaemia; Chronic lymphocytic leukaemia; Chronic myeloid leukaemia; Graft-versus-host disease; Haematological malignancies; Hodgkin's disease; Leukaemia; Lymphoma; Multiple myeloma; Myeloid leukaemia; Myeloproliferative disorders; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 20 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 03 Jan 2012 New trial record